Dietary supplement industry stakeholders are divided over whether proposed legislation to alter the regulatory definitions of dietary ingredients to specifically include CBD is the best way to break the logjam on the substance.
In this round up, we look at some of the new developments that took place in APAC’s health and nutrition regulatory space, including the South Korean authorities’ clampdown on influencers ads that made false health claims.
The year is new and a lot of people are getting out their crystal balls. NutraIngredients-USA is no exception, and here are our top big issues that will impact the dietary supplements industry in this new decade.
Building on a regulatory foundation already laid for hemp ingredients, Rep. Collin Peterson (D-MN) has proposed a bill that would include CBD under the definition of dietary supplements found in DSHEA.
A letter from a member of Congress to FDA calls into question the inconsistencies between the NDI process and how GRAS submissions are evaluated and the lack of communication between the staffs working on these issues.
By Stefan Gafner and Mark Blumenthal, American Botanical Council
The news about CBD and hemp extracts dominated 2019, says the American Botanical Council. But issues surrounding the ongoing climate crisis, questions of sustainability, and the ongoing questions of adulteration were important topics as well.
A paper published today in a prominent medical journal asserts that the law governing dietary supplements is no longer adequate to protect consumers and sweeping changes are needed to keep potentially dangerous new ingredients off the market.